Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
XERS
XERIS BIOPHARMA HOLDINGS INC
NASDAQ
Biotechnology
$752.73M$4.70-0.84%-$4.34M-15.67x-9.98
United States
NTRA
NATERA INC
NASDAQ
Diagnostics & Research
$22.93B$167.96-0.12%-$131.49M-114.26x0.40
United States
PFE
PFIZER INC
NYSE
Drug Manufacturers - General
$137.53B$24.19-0.21%$14.27B17.40x1.30
United States
TGTX
TG THERAPEUTICS INC
NASDAQ
Biotechnology
$5.83B$36.72-3.24%$70.41M136.00x1.77
United States
BLFS
BIOLIFE SOLUTIONS INC
NASDAQ
Medical Instruments & Supplies
$1.02B$21.490.05%-$2.50M-59.69x0.12
United States
SYK
STRYKER CORP
NYSE
Medical Devices
$150.40B$393.550.81%$3.76B52.47x1.20
United States
CORT
CORCEPT THERAPEUTICS INC
NASDAQ
Biotechnology
$7.76B$73.22-1.49%$110.98M57.65x0.24
United States
INMD
INMODE LTD
NASDAQ
Medical Devices
$975.70M$14.190.85%$140.61M6.04x0.14
Israel
BIO
BIO-RAD LABORATORIES INC
NYSE
Medical Devices
$6.64B$243.980.21%-$2.70B-3.21x0.43
United States
HCAT
HEALTH CATALYST INC
NASDAQ
Health Information Services
$265.18M$3.811.74%-$18.94M-3.31x1.37
United States
CNMD
CONMED CORP
NYSE
Medical Devices
$1.61B$52.17-0.32%$198.07M13.59x1.35
United States
ALKS
ALKERMES PLC
NASDAQ
Drug Manufacturers - Specialty & Generic
$4.75B$28.81-0.07%$463.88M13.40x0.38
Ireland
FTRE
FORTREA HOLDINGS INC
NASDAQ
Biotechnology
$448.20M$4.98-4.23%-$577.60M-0.57x2.63
United States
OSCR
OSCAR HEALTH INC
NYSE
Healthcare Plans
$5.20B$20.41-0.34%$197.24M42.52x3.38
United States
WHWK
WHITEHAWK THERAPEUTICS INC
NASDAQ
Biotechnology
$90.92M$1.931.58%$28.33M12.06x0.06
United States
ZYME
ZYMEWORKS INC
NASDAQ
Biotechnology
$868.95M$12.470.81%-$94.99M-8.31x0.31
Canada
TARS
TARSUS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.70B$40.350.05%-$93.78M-14.83x0.46
United States
TKNO
ALPHA TEKNOVA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$273.08M$5.110.00%-$15.95M-10.87x0.45
United States
TLX
TELIX PHARMACEUTICALS LTD
NASDAQ
Biotechnology
$5.36B$16.00-2.44%$58.49MN/A1.67
Australia
ZBH
ZIMMER BIOMET HOLDINGS INC
NYSE
Medical Devices
$18.10B$91.46-0.31%$2.29B20.19x0.79
United States
FLGT
FULGENT GENETICS INC
NASDAQ
Diagnostics & Research
$599.13M$19.680.41%-$21.59M-14.80x0.07
United States
CTMX
CYTOMX THERAPEUTICS INC
NASDAQ
Biotechnology
$181.40M$2.25-2.60%$47.70M4.59x2.93
United States
NBIX
NEUROCRINE BIOSCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$12.41B$125.42-1.02%$494.70M41.39x0.45
United States
KROS
KEROS THERAPEUTICS INC
NASDAQ
Biotechnology
$547.90M$13.49-0.15%$17.92M-112.42x0.08
United States
LGND
LIGAND PHARMACEUTICALS INC
NASDAQ
Biotechnology
$2.20B$114.15-1.33%-$119.89M-15.85x0.14
United States
DVA
DAVITA INC
NYSE
Medical Care Facilities
$10.70B$141.670.41%$2.35B13.71x-57.88
United States
ATEC
ALPHATEC HOLDINGS INC
NASDAQ
Medical Devices
$1.62B$11.081.65%-$52.52M-9.63x-10.14
United States
AGEN
AGENUS INC
NASDAQ
Biotechnology
$130.50M$4.76-3.05%-$76.47M-0.56x-1.53
United States
HSTM
HEALTHSTREAM INC
NASDAQ
Health Information Services
$840.97M$27.550.95%$65.17M43.73x0.44
United States
TXG
10X GENOMICS INC
NASDAQ
Health Information Services
$1.44B$11.730.26%-$111.37M-8.95x0.28
United States
CERS
CERUS CORP
NASDAQ
Medical Devices
$271.45M$1.424.41%-$5.95M-14.20x2.71
United States
TMO
THERMO FISHER SCIENTIFIC INC
NYSE
Diagnostics & Research
$154.12B$408.28-0.93%$11.29B23.89x1.01
United States
WST
WEST PHARMACEUTICAL SERVICES INC
NYSE
Medical Instruments & Supplies
$15.72B$218.87-0.06%$744.00M34.09x0.35
United States
SNY
SANOFI
NASDAQ
Drug Manufacturers - General
$120.88B$47.85-1.08%$11.90B20.69x0.71
France
WRBY
WARBY PARKER INC
NYSE
Medical Instruments & Supplies
$2.66B$21.891.91%$28.30M-182.42x0.93
United States
CON
CONCENTRA GROUP HOLDINGS PARENT INC
NYSE
Medical Care Facilities
$2.71B$21.152.22%$364.58M16.15x7.81
United States
ITGR
INTEGER HOLDINGS CORP
NYSE
Medical Devices
$4.28B$122.560.57%$290.43M53.52x1.05
United States
MRK
MERCK & CO INC
NYSE
Drug Manufacturers - General
$198.62B$79.100.34%$26.05B11.48x1.38
United States
TCMD
TACTILE SYSTEMS TECHNOLOGY INC
NASDAQ
Medical Devices
$240.39M$10.340.98%$31.62M15.43x0.36
United States
INGN
INOGEN INC
NASDAQ
Medical Devices
$190.36M$7.08-1.60%-$7.09M-6.16x0.56
United States
CERT
CERTARA INC
NASDAQ
Health Information Services
$1.85B$11.38-0.35%$83.59M-569.00x0.44
United States
CLOV
CLOVER HEALTH INVESTMENTS CORP
NASDAQ
Healthcare Plans
$1.40B$2.76-1.08%-$23.63M-55.20x0.74
United States
OMI
OWENS & MINOR INC
NYSE
Medical Distribution
$679.57M$8.876.48%$28.62M-1.86x7.51
United States
HAE
HAEMONETICS CORP
NYSE
Medical Instruments & Supplies
$3.55B$73.80-1.30%$337.40M22.16x1.99
United States
OMDA
OMADA HEALTH INC
NASDAQ
Health Information Services
N/A$17.61-1.45%N/AN/A-0.21
United States
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
NASDAQ
Biotechnology
$3.45B$39.60-2.96%-$32.47M-54.02x8.87
China
UTMD
UTAH MEDICAL PRODUCTS INC
NASDAQ
Medical Instruments & Supplies
$187.75M$57.802.41%$18.75M15.29x0.05
United States
ARQT
ARCUTIS BIOTHERAPEUTICS INC
NASDAQ
Biotechnology
$1.64B$13.74-4.58%-$100.65M-13.34x1.41
United States
GLUE
MONTE ROSA THERAPEUTICS INC
NASDAQ
Biotechnology
$282.95M$4.60-1.29%$17.73M57.50x0.43
United States
RGNX
REGENXBIO INC
NASDAQ
Biotechnology
$420.85M$8.39-4.11%-$122.44M-2.71x0.79
United States
SPRO
SPERO THERAPEUTICS INC
NASDAQ
Biotechnology
$164.38M$2.941.38%-$69.76M-2.30x1.30
United States
XGN
EXAGEN INC
NASDAQ
Diagnostics & Research
$126.02M$7.000.14%-$10.66M-8.33x5.29
United States
OGN
ORGANON & CO
NYSE
Drug Manufacturers - General
$2.56B$9.86-1.20%$1.48B3.39x23.27
United States
AMPH
AMPHASTAR PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.09B$23.08-0.43%$265.38M7.90x1.17
United States
HSIC
HENRY SCHEIN INC
NASDAQ
Medical Distribution
$8.92B$73.270.16%$971.00M22.61x1.74
United States
TVRD
TVARDI THERAPEUTICS INC
NASDAQ
Biotechnology
$230.37M$24.61-2.38%-$35.47M-0.82x-5.82
United States
CRON
CRONOS GROUP INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$732.30M$1.90-0.52%$9.12M13.57x0.04
Canada
IPSC
CENTURY THERAPEUTICS INC
NASDAQ
Biotechnology
$44.72M$0.52-8.63%-$8.40M-1.79x0.31
United States
SEM
SELECT MEDICAL HOLDINGS CORP
NYSE
Medical Care Facilities
$1.96B$15.271.73%$495.15M11.31x2.12
United States
SEER
SEER INC
NASDAQ
Biotechnology
$124.80M$2.122.91%-$79.33M-1.50x0.12
United States
FHTX
FOGHORN THERAPEUTICS INC
NASDAQ
Biotechnology
$269.79M$4.84-0.41%-$71.61M-3.56x-5.20
United States
AMWL
AMERICAN WELL CORP
NYSE
Health Information Services
$125.53M$7.945.03%-$120.16M-0.78x0.39
United States
TVTX
TRAVERE THERAPEUTICS INC
NASDAQ
Biotechnology
$1.31B$14.77-2.38%-$169.03M-5.29x15.72
United States
NRC
NATIONAL RESEARCH CORP
NASDAQ
Health Information Services
$379.83M$16.672.96%$41.22M16.03x3.56
United States
RPID
RAPID MICRO BIOSYSTEMS INC
NASDAQ
Medical Devices
$156.92M$3.582.87%-$42.88M-3.48x0.31
United States
MYNZ
MAINZ BIOMED NV
NASDAQ
Diagnostics & Research
$3.20M$1.38-1.43%-$19.56M-0.06x1.19
Germany
NTRB
NUTRIBAND INC
NASDAQ
Biotechnology
$89.01M$7.981.92%-$9.65M-8.87x0.21
United States
SIGA
SIGA TECHNOLOGIES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$461.51M$6.46-1.52%$62.82M9.50x0.14
United States
NVAX
NOVAVAX INC
NASDAQ
Biotechnology
$1.03B$6.37-2.00%$554.90M2.10x-18.09
United States
BRKR
BRUKER CORP
NASDAQ
Medical Devices
$6.33B$41.80-0.90%$359.40M80.38x2.24
United States
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
NASDAQ
Biotechnology
$1.79B$11.79-3.04%-$106.35M-12.41x1.68
United States
ACOG
ALPHA COGNITION INC
NASDAQ
Biotechnology
$145.86M$9.11-1.14%-$11.47M-7.00x0.19
Canada
TRAW
TRAWS PHARMA INC
NASDAQ
Biotechnology
$7.96M$1.430.00%-$34.60M-0.04x2.18
United States
MCRB
SERES THERAPEUTICS INC
NASDAQ
Biotechnology
$79.47M$9.10-4.31%$90.27M1.04x2.25
United States
IRWD
IRONWOOD PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$118.29M$0.73-6.04%$60.23M-3.66x-1.98
United States
IQV
IQVIA HOLDINGS INC
NYSE
Diagnostics & Research
$27.24B$157.47-0.44%$3.43B21.25x3.57
United States
SEPN
SEPTERNA INC
NASDAQ
Biotechnology
$468.31M$10.51-3.31%N/AN/A0.08
United States
EXAS
EXACT SCIENCES CORP
NASDAQ
Diagnostics & Research
$10.12B$53.653.55%-$758.08M-9.68x1.38
United States
MESO
MESOBLAST LTD
NASDAQ
Biotechnology
$1.26B$10.921.58%N/A-11.75x0.42
Australia
TSHA
TAYSHA GENE THERAPIES INC
NASDAQ
Biotechnology
$510.89M$2.38-1.24%-$84.24M-7.00x1.51
United States
KRYS
KRYSTAL BIOTECH INC
NASDAQ
Biotechnology
$4.01B$138.88-2.60%$144.76M32.15x0.09
United States
AORT
ARTIVION INC
NYSE
Medical Devices
$1.33B$31.191.86%$39.49M-62.38x1.69
United States
LNTH
LANTHEUS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$5.64B$81.490.93%$438.66M22.20x0.77
United States
ACIU
AC IMMUNE SA
NASDAQ
Biotechnology
$201.82M$2.01-3.83%-$60.62M-3.17x1.23
Switzerland
EUDA
EUDA HEALTH HOLDINGS LTD
NASDAQ
Health Information Services
$127.43M$3.43-4.19%-$15.14M-7.30x-1.67
Singapore
ATR
APTARGROUP INC
NYSE
Medical Instruments & Supplies
$10.29B$155.820.87%$781.95M27.92x0.78
United States
MTD
METTLER TOLEDO INTERNATIONAL INC
NYSE
Diagnostics & Research
$24.62B$1,184.54-0.73%$1.21B29.44x-18.78
United States
VTRS
VIATRIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$10.57B$9.01-1.21%-$530.80M-2.84x1.46
United States
LMAT
LEMAITRE VASCULAR INC
NASDAQ
Medical Instruments & Supplies
$1.87B$82.570.21%$69.65M40.88x0.60
United States
GH
GUARDANT HEALTH INC
NASDAQ
Diagnostics & Research
$6.30B$50.861.66%-$370.74M-15.00x-6.36
United States
ARGX
ARGENX SE
NASDAQ
Biotechnology
$34.03B$560.140.02%$114.32M37.02x0.13
Belgium
PTHL
PHETON HOLDINGS LTD
NASDAQ
Medical Devices
$259.92M$18.244.29%-$566.33k-350.77x0.09
China
AEON
AEON BIOPHARMA INC
NYSEMKT
Biotechnology
$8.58M$0.76-0.52%$169.21M0.00x-2.22
United States
IRTC
IRHYTHM TECHNOLOGIES INC
NASDAQ
Medical Devices
$4.94B$154.711.32%-$57.89M-49.27x9.69
United States
USPH
U S PHYSICAL THERAPY INC
NYSE
Medical Care Facilities
$1.20B$79.030.43%$77.39M36.25x0.85
United States
PRVA
PRIVIA HEALTH GROUP INC
NASDAQ
Health Information Services
$2.68B$22.000.00%$35.15M169.23x0.72
United States
DVAX
DYNAVAX TECHNOLOGIES CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.19B$9.91-0.30%-$40.59M-20.22x0.78
United States
ATAI
ATAI LIFE SCIENCES NV
NASDAQ
Biotechnology
$440.74M$2.20-2.22%-$144.77M-2.42x0.29
United States
NEO
NEOGENOMICS INC
NASDAQ
Diagnostics & Research
$924.03M$7.180.28%$8.02M-11.77x0.80
United States
RSLS
RESHAPE LIFESCIENCES INC
NASDAQ
Medical Devices
$1.80M$2.442.52%-$3.37M-0.01x4.27
United States

Healthcare Industries

IndustryStocks1d %1w %1m %1y %DD ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
651-0.86%+1.66%+3.82%-71.04%-117.68x4.43x-78.40%-3.20%+5.01%+105.31%Strong Buy
57-0.20%+1.70%+3.90%-18.06%19.78x3.56x-11.18%+5.91%+10.44%+15.00%Buy
18-1.14%+0.49%+2.53%-13.20%37.35x5.88x+50.69%+9.87%+16.83%+56.00%Buy
77-0.54%-3.06%+0.75%-60.50%-34.41x2.23x+9.59%+4.62%+10.59%+39.90%Buy
11+1.17%+1.88%+2.55%-20.99%14.25x2.04x+16.73%+5.28%+12.28%+23.54%Buy
56+1.14%+5.74%+4.64%-63.83%45.22x4.01x+8.21%+4.35%+9.43%+18.70%Buy
48+0.38%+2.07%-0.55%-8.57%16.76x4.65x-72.65%+6.84%+14.37%+19.11%Buy
139+0.34%+2.78%+0.80%-9.33%36.87x4.10x+7.86%+8.31%+8.96%+29.58%Strong Buy
10+0.68%+1.34%+2.04%+26.23%29.05x1,398.21x+0.00%+3.60%+22.79%+4.00%Buy
56+0.23%+2.85%-0.48%-61.26%40.93x3.67x+10.25%+8.46%+10.95%+25.85%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jul 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1123 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 19 points higher than the healthcare sector average of 26. It passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 49.19% over the past year, overperforming other healthcare stocks by 100 percentage points.

Phibro Animal Health has an average 1 year price target of $24.00, a downside of -6.47% from Phibro Animal Health's current stock price of $25.66.

Phibro Animal Health stock has a consensus Sell recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 0% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 50% have issued a Strong Sell.

2. Healthcare Services Group (NASDAQ:HCSG)


Healthcare Services Group (NASDAQ:HCSG) is the #2 top healthcare stock out of 1123 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Healthcare Services Group (NASDAQ:HCSG) is: Value: C, Growth: B, Momentum: B, Sentiment: B, Safety: A, Financials: C, and AI: B.

Healthcare Services Group (NASDAQ:HCSG) has a Due Diligence Score of 41, which is 15 points higher than the healthcare sector average of 26. It passed 16 out of 38 due diligence checks and has strong fundamentals. Healthcare Services Group has seen its stock return 40.19% over the past year, overperforming other healthcare stocks by 91 percentage points.

Healthcare Services Group has an average 1 year price target of $14.00, a downside of -6.23% from Healthcare Services Group's current stock price of $14.93.

Healthcare Services Group stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Healthcare Services Group, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Cumberland Pharmaceuticals (NASDAQ:CPIX)


Cumberland Pharmaceuticals (NASDAQ:CPIX) is the #3 top healthcare stock out of 1123 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Cumberland Pharmaceuticals (NASDAQ:CPIX) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: C.

Cumberland Pharmaceuticals (NASDAQ:CPIX) has a Due Diligence Score of 30, which is 4 points higher than the healthcare sector average of 26. It passed 9 out of 33 due diligence checks and has average fundamentals. Cumberland Pharmaceuticals has seen its stock return 71.05% over the past year, overperforming other healthcare stocks by 122 percentage points.

What are the healthcare stocks with highest dividends?

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Fresenius Medical Care Ag (NYSE:FMS)


Fresenius Medical Care Ag (NYSE:FMS) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 1.97%. Fresenius Medical Care Ag's dividend payout is not stable, having dropped more than 10% three times in the last 10 years. Fresenius Medical Care Ag's dividend has shown consistent growth over the last 10 years.

Fresenius Medical Care Ag's dividend payout ratio of 52.9% indicates that its dividend yield is sustainable for the long-term.

2. Select Medical Holdings (NYSE:SEM)


Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 12.45%, which is 10 percentage points higher than the healthcare sector average of 1.97%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 32.4% indicates that its high dividend yield is sustainable for the long-term.

3. Cryo Cell International (NYSEMKT:CCEL)


Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 7.71%, which is 6 percentage points higher than the healthcare sector average of 1.97%.

Cryo Cell International's dividend payout ratio of 5,000% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.14% in the last day, and up 1.88% over the last week. Ontrak was the among the top losers in the healthcare sector, dropping -43.17% yesterday.

Ontrak shares are trading lower after the company announced an approximately $4 million public offering.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 1.59% in the past year. It has overperformed other stocks in the healthcare sector by 53 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 26 points higher than the healthcare sector average of 17. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 3.1% in the past year. It has overperformed other stocks in the healthcare sector by 54 percentage points.

3. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Inmode's stock has dropped -21.43% in the past year. It has overperformed other stocks in the healthcare sector by 30 percentage points.

Are healthcare stocks a good buy now?

50.96% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 48.04% over the next year.

4.71% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.11% of healthcare stocks are rated B (Buy), 45.05% are rated C (Hold), 25.97% are rated D (Sell), and 13.16% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.2x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.